Osteoporosis treatment in Portugal: Trends and geographical variation;Tratamento da osteoporose em Portugal: Tendência e variação geográfica

Acta Medica Portuguesa

Volumn 19, Issue 5, 2006, Pages 373-380

  Rocha, Olavo ^a   Lunet, Nuno ^a   Costa, Lúcia ^a   Barros, Henrique ^a  

^a University of Porto   (Portugal)

Author keywords

Bisphosphonates; Calcitonin; Calcium; Hormone replacement therapy; Osteoporosis; Portugal; Raloxifene; Therapeutics; Trends; Vitamin D

Indexed keywords

ALENDRONIC ACID; ANDRONAT; BIONOCALCIN; BISPHOSPHONIC ACID DERIVATIVE; CALCIMON; CALCITONIN; CALCITONIN DERIVATIVE; CALCIUM; CALOGEN; CIBALCINA; CLIMARA DUO; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; CYPROTERONE ACETATE PLUS ESTRADIOL VALERATE; DIENOGEST PLUS ESTRADIOL VALERATE; DYDROGESTERONE PLUS ESTRADIOL; EMMENOVIS; ESTRADERME MX; ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTRADIOL VALERATE PLUS MEDROXYPROGESTERONE ACETATE; ESTRADIOL VALERATE PLUS NORGESTREL; ESTRADOT; ESTROFEM; ETIDRONIC ACID; OSTINATE 200; OSTOSALM; PREMARIN PLUS; PREMELLE CYCLE; RALOXIFENE; RISEDRONIC ACID; SALCAT; SALCATONIN; TIBOLONE; TONOCALTIN; UNCLASSIFIED DRUG; VITAMIN D;

ARTICLE; DRUG COST; DRUG MARKETING; DRUG USE; DRUG UTILIZATION; GEOGRAPHIC DISTRIBUTION; HORMONE SUBSTITUTION; HUMAN; OSTEOPOROSIS; PORTUGAL; AGED; COST; ECONOMICS; FEMALE; MIDDLE AGED;

AGED; CALCITONIN; CALCIUM; COSTS AND COST ANALYSIS; DIPHOSPHONATES; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; OSTEOPOROSIS; PORTUGAL; RALOXIFENE; VITAMIN D;

EID: 34249726796     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Osteoporosis: prevention, diagnosis, and therapy. JAMA 2001;285(6):785-95
2. LIPPUNER K, GOLDER M, GREINER R: Epidemiology and direct medical costs of osteoporotic fractures in men and women in Switzerland. Osteoporos Int 2005;16 Suppl 2:S8-S17
3. MORALES-TORRES J, GUTIERREZ-URENA S: The burden of osteoporosis in Latin America. Osteoporos Int 2004;15(8):625-32
4. rd: Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 1997;12(1):24-35
5. DOLAN P, TORGERSON DJ: The cost of treating osteoporotic fractures in the United Kingdom female population. Osteoporos Int 1998;8(6):611-7.
6. BROWN JP, JOSSE RG: 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2002;167(10 Suppl):S1-34.
7. HODGSON SF, WATTS NB, BILEZIKIAN JP et al: American Association of Clinical Endocrinologists 2001 Medical Guidelines for Clinical Practice for the Prevention and Management of Postmenopausal Osteoporosis. Endocr Pract 2001;7(4):293-312
8. ROSSOUW JE, ANDERSON GL, PRENTICE RL et al: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002;288(3):321-33
9. Documento 2003 de la Sociedad Española de Reumatología sobre la osteoporosis posmenopáusica. Rev Esp Reumatol 2003;30(10):565-71
10. Prontuário Terapêutico - 5: INFARMED; 2003 11. WHO: ATC/DDD Index 2006. [cited 2006 20 Janeiro]; Available from: http://www.whocc.no/atcddd/
11. INE: Estatísticas demográficas: Instituto Nacional de Estatística; 1998 a 2002.
12. INE: Estudo sobre o poder de compra concelhio. 2004 [cited 2006 20 de Janeiro]; Available from: http://www.ine.pt/
13. HERSH AL, STEFANICK ML, STAFFORD RS: National use of post-menopausal estrogen therapy: annual trends and response to recent evidence, 1995-2002. JAMA 2004;291:47-53
14. LEE E, ZUCKERMAN IH, WEISS SR: Patterns of pharmacotherapy and counseling for osteroporosis management in visits to US ambulatory care physicians by women. Arch Intern Med 2002;162:2362-6
15. STAFFORD RS, DRIELING RL, HERSH A: National trends in osteoporosis visits and osteoporosis treatment, 1988-2003. Arch Intern Med 2004;164:1525-30
16. SUNYECZ JA, WEISMAN SM: The role of calcium in osteoporosis drug therapy. J Womens Health (Larchmt) 2005;14(2):180-92
17. MARANTES I, BARROS H: Osteoporose: o que sabem e o que pensam as mulheres portuguesas. Arq Med 2004;18:78-82
18. SANDERS KM, NICHOLSON JC, UGONI AM, SEEMAN E, PASCO JA, KOTOWICZ MA: Fracture rates lower in rural than urban communities: the Geelong Osteoporosis Study. J Epidemiol Community Health 2002;56:466-70
19. ALVES S: Epidemiological descriptive study of osteoporosis in Portugal using geographical information systems [Master thesis]: University of Porto; 2005
20. INE: Anuários Estatísticos Regionais - Quadros Nacionais 2003. 2003 [cited 2006 20 de Janeiro]; Available from: http://www.ine.pt/